While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...

Poor Andhra villagers now victims of clinical drug trials No Drug Resistance     * 35 women, some men from Guntur district put throughclinical trials of a breast cancer drug. They later complain of joint pains, nausea and chest pains.     * Biotech industry in Andhra is worth about Rs 455 crore     * Touts operating on behalf of pharma companies get people from the poorer districts to Hyderabad for the tests *** Some 35 women...

-The United Nations   Twelve nations and the European Union today added their signatures to a United Nations treaty on the equitable sharing of the planet’s genetic resources in a ceremony at UN Headquarters. Representatives from Austria, Bulgaria, the Czech Republic, Denmark, Finland, Germany, Hungary, Italy, Luxembourg, Netherlands, Sweden, United Kingdom and the European Union signed the Nagoya Protocol on Access and Benefit Sharing, which calls for “fair and equitable sharing” of...

-The Hindu   Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Thursday demanded action against those responsible for allowing clinical trials of the human papillomavirus (HPV) vaccine in Andhra Pradesh and Gujarat without following the guidelines and ethics. Speaking at a seminar organised by the All-India Democratic Women's Association (AIDWA) here on “Cervical Cancer Vaccine — Consequences” the CPI(M) Rajya Sabha member said the poor in the country were...

Rs 3 lakh – that's the price a pharmaceutical company has paid to the family of a person who died in their clinical trial. Others weren't even this lucky. According to the Drug Controller General of India's (DCGI) records, 25 people died in clinical trials carried out by nine pharmaceutical companies in 2010. Families of five of these victims received "compensation for trial related death" — the amount ranging from Rs...